Courtney DiNardo, MD, Associate Professor at the University of Texas MD Anderson Cancer Center, explains how treatment strategies have changed for managing elderly patients with acute myeloid leukemia (AML).
AML is a rare blood cancer that tends to occur more often in the elderly. Standard chemotherapy for AML can be problematic in some elderly patients, especially those with other underlying conditions, but with the advent of ventoclax-based combinations, many elderly patients are more likely to tolerate the therapy.
For more information about AML and other rare cancers, visit https://checkrare.com/diseases/cancers/
